IBERE PHARMACEUTICALS

Ibere Pharmaceuticals (Nasdaq: IBER) is a blank check company that completed its initial public offering in 2021, targeting acquisition opportunities in the pharmaceutical and life sciences sector. The company filed a Form 10-Q with the Securities and Exchange Commission on August 16, 2021, reflecting its status as an active search-stage vehicle at that time. Ibere Pharmaceuticals was structured to identify and execute a business combination with a target operating in biopharma or adjacent healthcare verticals. For comprehensive filing history, deal status updates, and sponsor profiles on IBER and the full SPAC universe, sign up for complete data access at SpacDesk.